Galileo Acquisition Corp. (GLEO) Shareholders Approve Shapeways Deal
by Marlena Haddad on 2021-09-29 at 6:35am

Galileo Acquisition Corp. (NYSE:GLEO) announced in an 8-K filing this morning that its shareholders approved its combination with additive manufacturing firm Shapeways, albeit with high redemptions.

In connection with the special meeting held yesterday, 11,018,352 shares were redeemed, removing 79.8% of Galileo’s trust. This comes as somewhat of a surprise as Galileo has traded steadily above $10 since late July but opened $0.05 below its estimated pro rata trust value of $10.09 on the day of its redemption deadline, September 24.

The $75 million PIPE involved in the deal appears to have been just enough for the SPAC to maintain its $100 million minimum cash condition in the transaction. The deal is now expected to be completed today. The combined company’s shares and warrants are expected to begin trading on the NYSE under the symbols “SHPW” and “SHPW WS”, on September 30.

Galileo originally announced its $410 million combination with Shapeways on April 28. Shapeways provides a software platform for designers to have digitally-designed parts or products optimized and manufactured out of its Long Island City, NY facilities.

The business combination and all other measures on the ballot were passed by wide margins at the special meeting. For full vote tallies and descriptions of proposals, click HERE.


ADVISORS

  • Stifel is serving as the exclusive financial and capital markets advisor to Shapeways and as sole placement agent to Galileo for the PIPE.
  • EarlyBirdCapital is serving as financial and capital markets advisor to Galileo.
  • Needham & Company and Craig-Hallum are acting as capital markets advisors to Galileo.
  • Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP is serving as legal advisor to Shapeways.
  • Ellenoff Grossman & Schole LLP is serving as legal advisor to Galileo.
  • ICR is serving as investor relations and communications advisor to Shapeways.
Galileo Acquisition Corp. (GLEO) Shareholders Approve Shapeways Deal
Recent Posts
by Nicholas Alan Clayton on 2025-07-01 at 7:51pm

Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....

by Nicholas Alan Clayton on 2025-07-01 at 7:47pm

Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....

by Nicholas Alan Clayton on 2025-07-01 at 7:19pm

1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...

by Nicholas Alan Clayton on 2025-07-01 at 3:49pm

D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...

by Nicholas Alan Clayton on 2025-07-01 at 11:33am

Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved